| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.44 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |